These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15520670)

  • 1. Amyloid, tau, and cell death in Alzheimer's disease.
    Mariani SM
    MedGenMed; 2004 Aug; 6(3):46. PubMed ID: 15520670
    [No Abstract]   [Full Text] [Related]  

  • 2. Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease.
    Pluta R; Ouyang L; Januszewski S; Li Y; Czuczwar SJ
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the molecular pathology that underlies hippocampal memory decline?
    Harrington CR
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):703. PubMed ID: 19531682
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuronal death in Alzheimer's disease.
    Yanagisawa K
    Intern Med; 2000 Apr; 39(4):328-30. PubMed ID: 10801151
    [No Abstract]   [Full Text] [Related]  

  • 5. Testing the Amyloid Hypothesis with a Humanized AD Mouse Model.
    Cahill MK; Huang EJ
    Neuron; 2017 Mar; 93(5):987-989. PubMed ID: 28279360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid and tau in the brain in sporadic Alzheimer's disease: defining the chicken and the egg.
    Hawkes CA; Carare RO; Weller RO
    Acta Neuropathol; 2014 Apr; 127(4):617-8. PubMed ID: 24452628
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between amyloid and tau.
    Hardy J
    J Mol Neurosci; 2003 Apr; 20(2):203-6. PubMed ID: 12794314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: a route to drug discovery.
    Binder LI; Ghanbari HA
    Neurobiol Aging; 1994; 15 Suppl 2():S35-6. PubMed ID: 7700456
    [No Abstract]   [Full Text] [Related]  

  • 9. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.
    Tan CH; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Dillon WP; Bonham LW; Yokoyama JS; Karch CM; Brewer JB; Rabinovici GD; Miller BL; Schellenberg GD; Kauppi K; Feldman HA; Holland D; McEvoy LK; Hyman BT; Bennett DA; Andreassen OA; Dale AM; Desikan RS;
    Acta Neuropathol; 2018 Jan; 135(1):85-93. PubMed ID: 29177679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
    Ittner LM; Götz J
    Nat Rev Neurosci; 2011 Feb; 12(2):65-72. PubMed ID: 21193853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubule stabilizing drugs for the treatment of Alzheimer's disease.
    Lee VM; Daughenbaugh R; Trojanowski JQ
    Neurobiol Aging; 1994; 15 Suppl 2():S87-9. PubMed ID: 7700471
    [No Abstract]   [Full Text] [Related]  

  • 13. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of Alzheimer's disease].
    Ankri J
    Rev Neurol (Paris); 2003 Sep; 159(8-9):819-24. PubMed ID: 13679729
    [No Abstract]   [Full Text] [Related]  

  • 16. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
    Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
    Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking amyloid and tau pathology in Alzheimer's disease: the role of membrane cholesterol in Abeta-mediated tau toxicity.
    Wray S; Noble W
    J Neurosci; 2009 Aug; 29(31):9665-7. PubMed ID: 19657019
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein studies try to puzzle out Alzheimer's tangles.
    Roush W
    Science; 1995 Feb; 267(5199):793-4. PubMed ID: 7846523
    [No Abstract]   [Full Text] [Related]  

  • 19. A biological classification for Alzheimer's disease - Amyloid, Tau and Neurodegeneration (A/T/N): results from the Argentine-Alzheimer's Disease Neuroimaging Initiative.
    Allegri RF; Pertierra L; Cohen G; Chrem Méndez P; Russo MJ; Calandri I; Bagnati P; Tapajóz F; Clarens F; Campos J; Nahas FE; Surace E; Vázquez S; Sevlever G
    Int Psychogeriatr; 2019 Dec; 31(12):1837-1838. PubMed ID: 30859920
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma tau/amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease.
    Park JC; Han SH; Yi D; Byun MS; Lee JH; Jang S; Ko K; Jeon SY; Lee YS; Kim YK; Lee DY; Mook-Jung I
    Brain; 2019 Mar; 142(3):771-786. PubMed ID: 30668647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.